Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus plus steroid versus cyclophosphamide plus steroid for idiopathic membranous nephropathy with nephrotic syndrome
ChiCTR-TRC-11001144Phase 4Recruiting
- Sponsor
- Ruijin Hospital
- Start
- Jan 2008
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tacrolimus, cyclophosphamide and prednisone in idiopathic membranous glomerulonephritis (IMG) (2 arms), sponsored by Ruijin Hospital. Primary endpoints: 24-hour urinary protein excretion, serum albumin and 1 more. Started Jan 2008; status: recruiting.
02
Drugs
tacrolimuscyclophosphamideprednisone
03
Conditions
idiopathic membranous glomerulonephritis (IMG)
Beyond the preview
Go deeper on ChiCTR-TRC-11001144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001144.